Molecular imaging-monitored radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy for rat orthotopic ovarian cancer.

Conclusion: The feasibility of intratumoral RFH-enhanced HSV-TK/GCV gene therapy was established on a unique rat model with molecular imaging-detectable orthotopic ovarian cancer. PMID: 31969028 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31969028?dopt=Abstract

Source: International Journal of Hyperthermia - January 25, 2020 Category: Internal Medicine Tags: Int J Hyperthermia Source Type: research